Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases

Neuroscience

Volumn 214, Issue , 2012, Pages 68-77

  Louboutin, J P ^a   Agrawal, L ^a   Reyes, B A S ^a   Van Bockstaele, E J ^a   Strayer, D S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antioxidant enzymes; Apoptosis; Caspases; Gene therapy; Gp120; Human immunodeficiency virus type 1

Indexed keywords

CASPASE; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 1; GLYCOPROTEIN GP 120; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; ENZYME LOCALIZATION; ENZYME SYNTHESIS; FEMALE; GENE DELIVERY SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; CASPASE INHIBITORS; CASPASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; GLUTATHIONE PEROXIDASE; HIV ENVELOPE PROTEIN GP120; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84861829325     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.061     Document Type: Article

References (76)

1. Agrawal L., Louboutin J.P., Reyes B.A.S., van Bockstaele E.J., Strayer D.S. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis. Gene Ther 2006, 13:1645-1656.
2. Agrawal L., Louboutin J.P., Strayer D.S. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology 2007, 363:462-472.
3. Agrawal L., Louboutin J.P., Reyes B.A.S., van Bockstaele E.J., Strayer D.S. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol Dis 2012, 45:657-670.
4. Ahmed F., McArthur L., De Bernardi M., Mocchetti I. Retrograde and anterograde transport of HIV protein gp120 in the nervous system. Brain Behav Immun 2009, 23:355-364.
5. Ances B.M., Ellis R.J. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007, 27:86-92.
6. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
7. Askenov M.Y., Hasselrot U., Bansal A.K., Wu G., Nath A., Anderson C., et al. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 2001, 305:5-8.
8. Askenov M.Y., Hasselrot U., Wu G., Nath A., Anderson C., Mactutus C.F., et al. Temporal relationship between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 2003, 987:1-9.
9. Askenov M.Y., Askenova M.V., Mactutus C.F., Booze R.M. Attenuated neurotoxicity of the transactivation-defective HIV-Tat protein in hippocampal cell cultures. Exp Neurol 2009, 219:586-590.
10. Bachis A., Aden S.A., Nosheny R.L., Andrews P.M., Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. J Neurosci 2006, 26:6771-6780.
11. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995, 38:357-366.
12. Bonavia R., Bajetto A., Barbero S., Albini A., Noonan D.M., Schettini G. HIV-1 Tat causes apoptosis death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 2001, 288:301-308.
13. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995, 92:7162-7166.
14. Braun J.S., Prass K., Dirnagl U., Meisel A., Meisel C. Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 2007, 206:183-191.
15. Broughton B.R.S., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-e339.
16. Bruce-Keller A.J., Li Y.J., Lovell M.A., Kraemer P.J., Gary D.S., Brown R.R., et al. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 1998, 57:257-267.
17. Bruce-Keller A.J., Turchan-Cholewo J., Smart E.J., Geurin T., Chauhan A., Reid R., et al. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 2008, 56:1414-1427.
18. Cao W., Carney J.M., Duchon A., Floyd R.A., Chevion M. Oxygen free radicals involvement in ischemia and reperfusion of the brain injury to brain. Neurosci Lett 1998, 88:233-238.
19. Cordelier P., Calarota S.A., Pomerantz R.J., Xiaoshan J., Strayer D.S. Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector. J Interferon Cytokine Res 2003, 23:477-488.
20. Cordelier P., Van Bockstaele E., Calarota S.A., Strayer D.S. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. Mol Ther 2003, 7:801-810.
21. Cordelier P., Strayer D.S. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. Virus Res 2006, 118:87-97.
22. Cribbs D.H., Poon W.W., Rissman R.A., Blurton-Jones M. Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol 2004, 165:353-355.
23. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003, 348:1365-1375.
24. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci 2000, 20:2817-2824.
25. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., et al. Caspase-3: a vulnerability factor and a final effector in the apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000, 97:2875-2880.
26. Hartmann A., Troadec J.-D., Hunot S., Kikly K., Faucheux B.A., Mouatt-Prigent A., et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 2001, 21:2247-2255.
27. Hoehn B., Yenari M.A., Sapolsky R.M., Steinberg G.K. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003, 34:2489-2494.
28. James H.J., Sharer L.R., Zhang Q., Wang H.G., Epstein L.G., Reed J.C., Gelbard H.A. Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 1999, 25:380-386.
29. Kaul M., Garden G.W., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 19:988-994.
30. Kruman L.L., Nath A., Mattson M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998, 154:276-288.
31. Kruman I.I., Mattson M.P. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem 1999, 72:529-540.
32. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000, 288:335-339.
33. Louboutin J.P., Liu B., Reyes B.A.S., Van Bockstaele E.J., Strayer D.S. Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple CNS cell lineages. Stem Cells 2006, 24:2801-2809.
34. Louboutin J.P., Agrawal L., Reyes B.A.S., Van Bockstaele E.J., Strayer D.S. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther 2007, 14:1650-1661.
35. Louboutin J.P., Reyes B.A.S., Agrawal L., Van Bockstaele E.J., Strayer D.S. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors. Gene Ther 2007, 14:939-949.
36. Louboutin J.P., Agrawal L., Reyes B.A.S., Van Bockstaele E.J., Strayer D.S. A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors. J Neuropathol Exp Neurol 2009, 68:456-473.
37. Louboutin J.P., Agrawal L., Reyes B.A.S., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes. Neurobiol Dis 2009, 34:462-476.
38. Louboutin J.P., Chekmasova A.A., Marusich E., Chowdhury J.R., Strayer D.S. Efficient CNS gene delivery by intravenous injection. Nat Meth 2010, 7:905-907.
39. Louboutin J.P., Agrawal L., Reyes B.A.S., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J Neuropathol Exp Neurol 2010, 69:801-816.
40. Louboutin J.P., Reyes B.A.S., Agrawal L., Van Bockstaele E.J., Strayer D.S. Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120- Protection by gene delivery of antioxidant enzymes. Neurobiol Dis 2010, 38:313-325.
41. Louboutin J.P., Reyes B.A.S., Agrawal L., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes. Exp Neurol 2010, 221:231-245.
42. Louboutin J.P., Marusich E., Fisher-Perkins J., Dufour J., Bunnell B.A., Strayer D.S. Gene transfer to the Rhesus monkey brain using SV40-derived vectors is durable and safe. Gene Ther 2011, 8:682-691.
43. Louboutin J.P., Reyes B.A.S., Agrawal L., Van Bockstaele E.J., Strayer D.S. Intracisternal rSV40 administration provides effective pan-CNS transgene expression. Gene Ther 2012, 19:114-118.
44. McArthur J.C., Brew B.J., Nath A. Neurological complications of HIV infection. Lancet Neurol 2005, 4:543-555.
45. McKee H.J., Strayer D.S. Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector. Vaccine 2002, 20:3613-3625.
46. Madden S.D., Cotter T.G. Cell death in brain development and degeneration: control of caspase expression may be key!. Mol Neurobiol 2008, 37:1-6.
47. Mandel R.J., Rendahl K.G., Spratt S.K., Snyder R.O., Cohen L.K., Leff S.E. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J Neurosci 1998, 18:4271-4284.
48. Martinou J.-C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., et al. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13:1017-1030.
49. Mattson M.P., Haughey N.J., Nath A. Cell death in HIV dementia. Cell Death Diff 2005, 12:893-904.
50. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 2001, 24:411-416.
51. Morinville A., Cahill C.M., Aibak H., Rymar V.V., Pradhan A., Hoffert C., et al. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 2004, 24:5549-5559.
52. Nath A., Sacktor N. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Curr Opin Neurol 2006, 19:358-361.
53. Nikonov A.A., Finger T.E., Caprio J. Beyond the olfactory bulb: an odotopic map in the forebrain. Proc Natl Acad Sci USA 2005, 102:18688-18693.
54. Noorbakhsh F., Ramachandran R., Barsby N., Ellestad K.K., LeBlanc A., Dickie P., et al. MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J 2010, 24:1799-1812.
55. Nosheny R.L., Bachis A., Aden S.A., De Bernardi M.A., Mocchetti I. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J Neurobiol 2006, 66:1311-1321.
56. Nosheny R.L., Ahmed F., Yakoviev A., Meyer E.M., Ren K., Tessarollo L., et al. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci 2007, 25:2275-2284.
57. Ona V.O., Li M., Vonsattel J.P., Andrews L.J., Khan S.Q., Chung W.M., et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 1999, 399:263-267.
58. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York, NY. 2nd ed.
59. Petito C.K., Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995, 146:1121-1130.
60. Ribe E.M., Serrano-Saiz E., Akpan N., Troy C.M. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 2008, 415:165-182.
61. Ridet J.L., Bensadoun J.C., Deglon N., Aebischer P., Zurn A.D. Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. Neurobiol Dis 2006, 21:29-34.
62. Rohn T.T., Head E. Caspases as therapeutic targets in Alzheimer's disease: is it time to 'cut' the chase?. Int J Clin Exp Pathol 2009, 2:108-118.
63. Rohn T.T. The role of caspases in Alzheimer's disease: potential novel therapeutic opportunities. Apoptosis 2010, 15:1403-1409.
64. Rouger K., Louboutin J.P., Villanova M., Cherel Y., Fardeau M. X-linked vacuolated myopathy: TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma. Am J Pathol 2001, 158:355-359.
65. Sauter B.V., Parashar B., Chowdhury N.R., Kadakol A., Ilan Y., Singh H., et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Gastroenterology 2000, 119:1348-1357.
66. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999, 5:97-100.
67. Sims N.R., Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010, 1802:80-91.
68. Singh I.N., Goody R.J., Dean C., Ahmad N.M., Lutz S.E., Knapp P.E., et al. Apoptotic cell death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J Neurovirol 2004, 10:141-151.
69. Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical ageing in Alzheimer's disease. Trends Neurosci 1995, 18:172-176.
70. Strayer D.S., Kondo R., Milano J., Duan L.X. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther 1997, 4:219-225.
71. Strayer D.S. Gene therapy using SV40-derived vectors: what does the future hold?. J Cell Physiol 1999, 181:375-384.
72. Strayer D.S., Lamothe M., Wei D., Milano J., Kondo R. Generation of recombinant SV40 vectors for gene transfer. SV40 protocols. Methods in molecular biology 2001, Vol. 165:103-117. Humana Press, Totowa, NJ.
73. Turchan J., Pocernich C.B., Gairola C., Chauhan A., Schifitto G., Butterfield D.A., et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003, 60:307-314.
74. Turmel H., Hartmann A., Parain K., Douhou A., Srinivasan A., et al. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Exp Neurol 2001, 16:185-189.
75. Vukosavic S., Stefanis L., Jackson-Lewis V., Guegan C., Romero N., Chen C., et al. Delaying caspase activation by Bcl-2. A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2000, 20:9119-9125.
76. Watanabe Y., Chu Y., Andresen J.J., Nakane H., Faraci F.M., Heistad D.D. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003, 34:434-440.